Form 4 for GANX Gain Therapeutics, Inc.
Accepted 2023-09-22 00:00:00 ET · period of report 2023-09-20 · accession 0001209191-23-050380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-22 | 2023-09-20 | GANX | RICHMAN ERIC I | Dir | M - OptEx | — | +54.9K | 272.6K | +25% | — |
| D | 2023-09-22 | 2023-09-20 | GANX | RICHMAN ERIC I | Dir | M - OptEx | $0.00 | -54.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-20 | M | A | 54,900 | — | 272,629 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. |
| 2 | Derivative | Restricted Stock Units | 2023-09-20 | M | D | 54,900 | $0.00 | 0 | D | — · — to — | 54,900 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. (F3) The RSUs vested fully on September 20, 2023. |